Agenus (NASDAQ: AGEN) awards 1.97M performance-tied stock options to CEO
Rhea-AI Filing Summary
Agenus Inc granted Chairman and CEO Armen Garo H stock options covering 1,971,500 shares of common stock at an exercise price of $7.78 per share, expiring on August 10, 2036. The award is split into five equal performance-vesting tranches. Each tranche vests only if the share price reaches and sustains, for 30 consecutive days within a five-year performance period, a level equal to 3x, 4x, 5x, 6x, and 8x the $7.78 measurement price, and is also subject to a minimum three-year service requirement.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
ARMEN GARO H
Role
See Remarks
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option F1 | 1,971,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 1,971,500 shares (Direct)
Footnotes (1)
- F1. Option awarded in accordance with the Agenus Inc. Amended and Restated 2019 Equity Incentive Plan. The options are divided into five equal tranches, each of which vests only if the Company's stock price achieves and sustains, for 30 consecutive calendar days during the five-year performance period, a level equal to 3x, 4x, 5x, 6x, and 8x, respectively, of the measurement price of $7.78 per share, subject in each case to a minimum three-year service requirement.
Key Figures
Options Granted: 1,971,500 shares
Exercise Price: $7.78 per share
Expiration Date: August 10, 2036
+4 more
7 metrics
Options Granted
1,971,500 shares
Stock options awarded to CEO Armen Garo H
Exercise Price
$7.78 per share
Conversion or exercise price of the granted stock options
Expiration Date
August 10, 2036
Expiration of the granted stock options
Performance Period
five years
Period during which stock price hurdles must be achieved
Service Requirement
three years
Minimum service required for vesting of each tranche
Price Hurdles
3x, 4x, 5x, 6x, 8x of $7.78
Stock price levels required for each tranche to vest
Consecutive Days Requirement
30 days
Stock price must be sustained at hurdle level for vesting
Key Terms
Equity Incentive Plan, performance period, measurement price, stock option
4 terms
Equity Incentive Plan financial
"Option awarded in accordance with the Agenus Inc. Amended and Restated 2019 Equity Incentive Plan."
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
performance period financial
"for 30 consecutive calendar days during the five-year performance period, a level equal to 3x,"
The performance period is the specific time span over which an investment’s results, an employee’s targets, or a fund’s returns are measured and judged. It matters to investors because the length and start/end of that window determine which gains or losses count toward performance fees, bonus payouts, or benchmark comparisons—much like timing a race decides who wins, the chosen period can change whether results look strong or weak.
measurement price financial
"a level equal to 3x, 4x, 5x, 6x, and 8x, respectively, of the measurement price of $7.78 per share,"
stock option financial
"Option awarded in accordance with the Agenus Inc. Amended and Restated 2019 Equity Incentive Plan."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
FAQ
What did Agenus (AGEN) report in this Form 4 for Armen Garo H?
Agenus reported a grant of stock options to Chairman and CEO Armen Garo H for 1,971,500 shares at a $7.78 exercise price, expiring in 2036, under the Amended and Restated 2019 Equity Incentive Plan.
How many stock options were granted to the Agenus (AGEN) CEO and at what price?
The CEO received stock options on 1,971,500 shares of Agenus common stock with an exercise price of $7.78 per share. These options represent a single award divided into five equal performance-based tranches subject to stock price hurdles and service conditions.
What performance conditions apply to the Agenus (AGEN) CEO’s new option grant?
Each of the five equal tranches vests only if Agenus’s stock reaches and sustains, for 30 consecutive days, 3x, 4x, 5x, 6x, and 8x the $7.78 measurement price during a five-year performance period, plus a minimum three-year service requirement.
When do the newly granted Agenus (AGEN) options to the CEO expire?
The granted stock options covering 1,971,500 shares expire on August 10, 2036. Vesting depends on achieving specified stock price hurdles over 30 consecutive days within a five-year performance period and meeting a minimum three-year service condition.
Are the Agenus (AGEN) CEO’s new options time-based or performance-based?
The options are primarily performance-based, divided into five equal tranches that vest only upon achieving defined stock price multiples of $7.78 for 30 days, within a five-year performance period, and subject to a three-year minimum service requirement.
AI-generated analysis. How Rhea-AI works. Not financial advice.
